Prevalence of age-related macular degeneration in the US population.

OBJECTIVE To examine the prevalence of age-related macular degeneration (AMD) in non-Hispanic white, non-Hispanic black, Mexican American, and other racial/ethnic groups. DESIGN A US nationally representative, population-based, cross-sectional study involving a total of 5553 persons aged 40 years and older from the 2005-2008 National Health and Nutrition Examination Survey. The main outcome measure was AMD determined by the grading of 45° digital images from both eyes using a standardized protocol. RESULTS In the civilian, noninstitutionalized, US population aged 40 years and older, the estimated prevalence of any AMD was 6.5% (95% confidence interval, 5.5-7.6) and the estimated prevalence of late AMD was 0.8% (95% confidence interval, 0.5-1.3). Non-Hispanic black persons aged 60 years and older had a statistically significantly lower prevalence of any AMD than non-Hispanic white persons aged 60 years and older (odds ratio = 0.37; 95% confidence interval, 0.21-0.67). CONCLUSIONS Overall, the prevalence of any AMD in the 2005-2008 National Health and Nutrition Examination Survey was 6.5%, which is lower than the 9.4% prevalence reported in the 1988-1994 Third National Health and Nutrition Examination Survey. While this finding might be explained in part by possible methodological differences, these estimates are consistent with a decreasing incidence of AMD and suggest important public health care implications.

[1]  R. Klein,et al.  The Wisconsin age-related maculopathy grading system. , 1991, Ophthalmology.

[2]  R. Klein,et al.  Forecasting age-related macular degeneration through 2050. , 2009, JAMA.

[3]  D. Friedman,et al.  Racial differences in the prevalence of age-related macular degeneration: the Baltimore Eye Survey. , 1999, Ophthalmology.

[4]  Sharon D. Solomon,et al.  Racial differences in the prevalence of age-related macular degeneration: the Salisbury Eye Evaluation (SEE) Project. , 2008, Archives of ophthalmology.

[5]  R. Klein,et al.  The prevalence of age-related maculopathy by geographic region and ethnicity. The Colorado-Wisconsin Study of Age-Related Maculopathy. , 1997, Archives of ophthalmology.

[6]  P. Mitchell,et al.  Smoking and age-related macular degeneration: a review of association , 2005, Eye.

[7]  E. Souied,et al.  [Epidemiology of age related macular degeneration]. , 2009, Journal Francais d'Ophtalmologie.

[8]  R. Klein,et al.  Prevalence of age-related macular degeneration in a population-based sample of Hispanic people in Arizona: Proyecto VER. , 2005, Archives of ophthalmology.

[9]  Ronald Klein,et al.  The epidemiology of age-related macular degeneration. , 2004, American journal of ophthalmology.

[10]  R. Klein,et al.  Birth cohort effect on prevalence of age-related maculopathy in the Beaver Dam Eye Study. , 2003, American journal of epidemiology.

[11]  R. Klein,et al.  Prevalence of age-related maculopathy in the Atherosclerosis Risk in Communities Study. , 1999, Archives of ophthalmology.

[12]  R. Klein,et al.  Physical activity and the 15-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study , 2006, British Journal of Ophthalmology.

[13]  G. Foster,et al.  National Health and Nutrition Examination Survey , 2005 .

[14]  D. Holt,et al.  Methods of weighting for unit non-response , 1991 .

[15]  R. Klein,et al.  Age-period-cohort effect on the incidence of age-related macular degeneration: the Beaver Dam Eye Study. , 2008, Ophthalmology.

[16]  R. Klein,et al.  The relationship of age-related maculopathy, cataract, and glaucoma to visual acuity. , 1995, Investigative ophthalmology & visual science.

[17]  V. Preedy,et al.  National Health and Nutrition Examination Survey , 2010 .

[18]  S C Jensen,et al.  Age-related maculopathy in a multiracial United States population: the National Health and Nutrition Examination Survey III. , 1999, Ophthalmology.

[19]  R. Klein,et al.  Prevalence of age-related macular degeneration in Latinos: the Los Angeles Latino eye study. , 2004, Ophthalmology.

[20]  R. Klein,et al.  Detection of age-related macular degeneration using a nonmydriatic digital camera and a standard film fundus camera. , 2004, Archives of ophthalmology.

[21]  J. Saaddine,et al.  Forecasting age-related macular degeneration through the year 2050: the potential impact of new treatments. , 2009, Archives of ophthalmology.

[22]  S. Blair,et al.  Cardiorespiratory fitness levels among US adults 20-49 years of age: findings from the 1999-2004 National Health and Nutrition Examination Survey. , 2010, American journal of epidemiology.

[23]  Don H. Anderson,et al.  Extended haplotypes in the complement factor H (CFH) and CFH-related (CFHR) family of genes protect against age-related macular degeneration: characterization, ethnic distribution and evolutionary implications. , 2006, Annals of medicine.

[24]  R. Klein,et al.  Cataracts and macular degeneration in older Americans. , 1982, Archives of ophthalmology.

[25]  Don H. Anderson,et al.  Extended haplotypes in the complement factor H (CFH) and CFH‐related (CFHR) family of genes protect against age‐related macular degeneration: Characterization, ethnic distribution and evolutionary implications , 2006, Annals of medicine.

[26]  R. Klein,et al.  Early age-related maculopathy in the cardiovascular health study. , 2003, Ophthalmology.

[27]  Jennifer I. Lim,et al.  A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. , 2001, Archives of ophthalmology.

[28]  R. Guymer,et al.  Cost-effectiveness of smoking cessation to prevent age-related macular degeneration. , 2008, Cost effectiveness and resource allocation : C/E.

[29]  R. Klein,et al.  Racial/ethnic differences in age-related maculopathy. Third National Health and Nutrition Examination Survey. , 1995, Ophthalmology.

[30]  M. C. Leske,et al.  Features of Age-Related Macular Degeneration in a Black Population , 1995 .

[31]  R. Klein,et al.  Causes and prevalence of visual impairment among adults in the United States. , 2004, Archives of ophthalmology.

[32]  M. C. Leske,et al.  Nine-year incidence of age-related macular degeneration in the Barbados Eye Studies. , 2006, Ophthalmology.

[33]  R. Klein,et al.  Prevalence of age-related macular degeneration in 4 racial/ethnic groups in the multi-ethnic study of atherosclerosis. , 2006, Ophthalmology.